IMC-Chicago, LLC - VERTEX PHARMACEUTICALS INC ownership

VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 5 filers reported holding VERTEX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IMC-Chicago, LLC ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,656,746
+3.6%
47,900
+4.8%
0.02%0.0%
Q2 2023$16,082,287
+18.7%
45,700
+6.3%
0.02%
-6.2%
Q1 2023$13,548,010
+11.2%
43,000
+1.9%
0.02%
-15.8%
Q4 2022$12,186,516
+43.2%
42,200
+43.5%
0.02%
+72.7%
Q3 2022$8,512,000
+79.2%
29,400
+61.5%
0.01%
+120.0%
Q1 2022$4,750,000
+89.6%
18,200
+71.7%
0.01%
+66.7%
Q4 2020$2,505,000
+243.6%
10,600
+140.9%
0.00%
+50.0%
Q4 2018$729,0004,4000.00%
Other shareholders
VERTEX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 99,400$34,565,3560.12%
SIMPLEX TRADING, LLC 61,500$21,3860.02%
IMC-Chicago, LLC 47,900$16,656,7460.02%
JANE STREET GROUP, LLC 119,000$41,381,0600.01%
Allianz Asset Management GmbH 19,700$6,850,4780.01%
SG Americas Securities, LLC 59,600$5930.01%
Maven Securities LTD 900$312,9660.00%
JPMORGAN CHASE & CO 40,500$14,083,4700.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
OSAIC HOLDINGS, INC. 1$5,4200.00%
View complete list of VERTEX PHARMACEUTICALS INC shareholders